The Baltic Congress in Laboratory Medicine will be held on 6-7 November 2020 as an online event. The scientific program will provide insights into actual topics such as COVID-19, new updates on pediatrics, microbiology, infectiology and the use of new technologies. Labquality will be participating in the Congress as one of the sponsors.
Quality assurance of Covid-19 diagnostic tests
Labquality provides full external quality assessment programs for COVID-19 testing. External quality assessment schemes for SARS-CoV-2 nucleic acid testing and antibodies were introduced already in spring 2020, and an EQA scheme for antigen detection will start in January 2021.
Available External Quality Assessment schemes
- 5677 SARS-CoV-2, antibodies
- 5676 SARS-CoV-2, nucleic acid detection
- 5681 SARS-CoV-2, antigen detection
Read more and download the EQA Product Catalogue 2021
Labquality also provides new high-quality control and reference materials for internal quality control and test verification of COVID-19 diagnostic tests.
Microbix REDx SARS-CoV-2 controls for nucleic acid testing
- REDx™ SARS-CoV-2 Positive Control and Negative Control
- REDx™FLOQ® SARS-CoV-2 Swab Positive Control and Swab Negative Control
For more information: info@labquality.fi
Share this article
